Abstract
spectrum disorder (ASD). Comprehensive and multidisciplinary evaluation of patients with ID or ASD is essential for
prudent management of any probable underlying condition. Herein we report a 4 years and 3 months old boy with
speech delay, previously admitted to other clinics many times without any definite diagnosis. Physical examination
revealed that he had hyperactivity, poor eye contact and dysmorphic features. He had global developmental delay and
symptoms of ASD. The patient who had dysmorphic features was referred to pediatric genetics department with the
suspicion of FXS. Southern Blot analysis revealed CGG repeat expansion in the range of full mutation. Maternal southern
blot analysis revealed expanded CGG repeat in the range of premutation, and the family was given genetic counseling.
The patient is still being followed-up at the developmental pediatrics department with an individual education program
and other supportive treatments.
Children with FXS typically present with developmental delay. Although motor delays are often seen, these tend to be
mild, and affected males most commonly come to hospital because of speech delay as the patient in this case. The
present patient has both FXS and ASD diagnosis. As children with FXS may not have gross physical features, any child
who has developmental delay, borderline intellectual abilities, ID or ASD with an unknown etiology should undergo
molecular testing for fragile X syndrome. It was aimed in this case to emphasize the importance of comprehensive and
multidisciplinary evaluation of all patients referred with speech delay.
References
- 1. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 2009;85: 503–14.
- 2. Yu TW, Berry-Kravis E. Autism and fragile X syndrome. Semin Neurol 2014; 34: 258–65.
- 3. Berry-Kravis E, Grossman AW, Crnic LS, Greenough WT. Understanding fragile X syndrome. Curr Pediatr 2002;12:316–24.
- 4. Hersh JH, Saul RA. Committee on genetics. Health supervision for children with fragile X syndrome. Pediatrics 2011;127: 994–1006.
- 5. Bailey DB, Skinner D, Sparkman KL. Discovering fragile X syndrome: Family experiences and perceptions. Pediatrics 2003; 111:407–16.
- 6. Hagerman RJ, Hagerman PJ. Fragile X syndrome: Diagnosis, treatment, and research. 3rd ed. Baltimore, MD: Johns Hopkins University Press, 2002.
- 7. Berry-Kravis E, Sumis A, Hervey C, Mathur S. Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome. Int J Pediatr 2012;2012: 843016.
Abstract
References
- 1. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 2009;85: 503–14.
- 2. Yu TW, Berry-Kravis E. Autism and fragile X syndrome. Semin Neurol 2014; 34: 258–65.
- 3. Berry-Kravis E, Grossman AW, Crnic LS, Greenough WT. Understanding fragile X syndrome. Curr Pediatr 2002;12:316–24.
- 4. Hersh JH, Saul RA. Committee on genetics. Health supervision for children with fragile X syndrome. Pediatrics 2011;127: 994–1006.
- 5. Bailey DB, Skinner D, Sparkman KL. Discovering fragile X syndrome: Family experiences and perceptions. Pediatrics 2003; 111:407–16.
- 6. Hagerman RJ, Hagerman PJ. Fragile X syndrome: Diagnosis, treatment, and research. 3rd ed. Baltimore, MD: Johns Hopkins University Press, 2002.
- 7. Berry-Kravis E, Sumis A, Hervey C, Mathur S. Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome. Int J Pediatr 2012;2012: 843016.
Details
| Primary Language | English |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | Case Report |
| Authors | |
| Publication Date | December 30, 2018 |
| Submission Date | February 4, 2018 |
| Published in Issue | Year 2018 Volume: 12 Issue: 4 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 6 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.